Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you are taking Mounjaro and have surgery coming up, the most important thing to do is tell your healthcare team before the procedure — including the anaesthetist. Mounjaro (tirzepatide) slows gastric emptying, which affects how quickly food and liquid leave your stomach, and that has real implications for anaesthetic safety. This is not a reason to panic, and it is not a reason to stop treatment without guidance; it is a reason to have a clear, timely conversation with the people planning your care. The right information, passed on early, lets your team prepare properly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Under general or deep sedation anaesthesia, the body's normal reflexes (including the ability to protect the airway from stomach contents) are suppressed. This is why anaesthetists ask patients to fast beforehand: an empty stomach is a safer stomach. Mounjaro works partly by slowing how fast the stomach empties its contents into the small intestine. That is a useful mechanism for weight management (it prolongs the feeling of fullness) but it means that food eaten well before surgery may still be present when the anaesthetic is given.
The risk, in plain terms, is pulmonary aspiration: stomach contents passing into the lungs. It is uncommon but serious. Anaesthetists are trained to manage this risk, and being told about your medication in advance gives them the chance to adjust your fasting period, choose a different technique, or take additional precautions. Keeping it to yourself removes that option.
It is worth knowing that this applies even if you feel fine and have no GI symptoms. Delayed emptying can occur without any obvious signs, so fasting duration and the presence of tirzepatide in your system both matter to your team's calculations, and our page on tirzepatide duration explains how long the drug remains active after each dose. NHS England's guidance on weight management medicines specifically advises patients to disclose tirzepatide use to their anaesthetist before any surgical procedure.
It means more than mentioning it on a form. When your pre-operative assessment is scheduled (which is often a week or more before an elective operation) make sure Mounjaro is listed alongside every other medicine you take. If you have a pre-assessment phone call rather than an in-person appointment, say it out loud: 'I am currently taking tirzepatide, brand name Mounjaro, once a week for weight management.'
If the surgery is urgent or unplanned, tell the admitting team as soon as possible. Carry the name of your medication with you, or take a photo of your pen and the carton so the details are easy to share.
Your surgical team may also want to know your current dose and when your last injection was. The timing matters because, as our page on tirzepatide duration of action covers in more detail, the drug has a half-life that means it stays active in the body for roughly a week after each dose, and understanding this can help you prepare for that conversation.
This is where the SK3 framing matters most: you are not the one making this clinical decision alone, and neither is this page. The question of whether to pause tirzepatide before an operation (and for how long) depends on the nature of the procedure, the type of anaesthesia, your overall health, how your treatment is going, and your surgical team's own protocols. Some teams follow detailed pre-operative GLP-1 guidance; others are still developing their approach as clinical evidence evolves.
What is clear from NHS England's clinical guidance on weight management injections is that disclosure is non-negotiable, and that any decision about pausing or continuing treatment sits with your prescriber and surgical team together, not with the patient acting unilaterally. Do not stop Mounjaro without that conversation; abrupt changes in treatment have their own implications for appetite and blood sugar regulation.
If you are a nume patient with a procedure coming up, our prescribers are available through our aftercare team seven days a week to help you think through what to raise with your surgical team and what information to take with you.
Recovery from surgery sometimes means a period of reduced oral intake, post-operative nausea from the anaesthetic itself, or restricted diet. If you are also taking Mounjaro, whose most common side effects are gastrointestinal (nausea, vomiting, and changes in bowel habit) the post-operative period can feel harder than expected. Some patients also ask about using medicines like loperamide alongside their treatment, and our page on loperamide and Mounjaro explains what you should know before combining the two. Dehydration is a genuine concern worth taking seriously; our page on tirzepatide and dehydration outlines the signs to watch for and when to seek help.
Your surgical team will give you specific post-operative dietary and hydration guidance. If your appetite is already reduced from Mounjaro, eating enough protein during recovery needs attention, wound healing and muscle recovery both depend on adequate protein intake, and the appetite suppression from tirzepatide does not disappear because you have had an operation. Tell your nurses and doctors what you are taking so they can factor it into your recovery plan.
Once you are recovering and thinking about returning to your usual routine, it is also sensible to check how long your Mounjaro pen remains valid after opening before resuming your injections, particularly if there has been a gap during your recovery period. Our full Mounjaro guide covers the practical side of long-term treatment. If you are considering starting treatment once your recovery is complete, you can start a free consultation with a GPhC-registered prescriber who will assess your full medical picture, including any recent surgical history.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.